Skip to content

Midline incisional hernia prophylaxis using synthetic mesh in emergency or urgency gastrointestinal tract surgery: A multicenter randomized clinical trial

Midline incisional hernia prophylaxis using synthetic mesh in emergency or urgency gastrointestinal tract surgery: A multicenter randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200924002
Enrollment
470
Registered
2020-09-24
Start date
2020-11-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

emergency/urgency operated gastrointestinal conditions prophylactic mesh retrorectus mesh incisional hernia

Interventions

Light&#45
weight polypropylene mesh will be placed in retrorectus plane to augment fascia closure,closure will be performed with small tissue bites&#44
continuous monofilament suture
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
retrorectus mesh augmentation,primary suture closure

Sponsors

Vajira Hospital, Navamindradhiraj University
Lead Sponsor
Ramathibodi hospital&#44
Collaborator
Mahidol University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adults age ≥ 18 years 2. Surgery within 24 hours after admission or consultation with suspected GI pathology 3. Receipt of midline abdominal incision with an incision length of at least 1/4 of the distance from the xiphoid process to the pubic symphysis 4. Have an American Society of Anesthesiologist (ASA) physical status class 1-4

Exclusion criteria

Exclusion criteria: 1. Any of following conditions: 1.1. Septic shock (hemodynamic instability) 1.2. Metastatic cancer (stage IV) at before or during operation 1.3. Dirty surgical wound with severe contamination from fecal material and frank pus (surgical wound class IV) 1.4. Massive devitalized bowel ischemia 2. potential second-look operation or planned revisionary surgery via a midline incision 3. secondary fascial closure 4. existence of midline incisional hernia and/or history of midline incisional hernia repair 5. pregnancy or plan for pregnancy after surgery 6. connective tissue disorders 7. current or planned immunosuppressive use 8. allergy to polypropylene

Design outcomes

Primary

MeasureTime frame
incisional hernia at 3, 6, 12, 18, and 24 months detected by clinical examination and/or radiologic study

Secondary

MeasureTime frame
surgical site infection at 1, 3, 6, and 12 months superficial and deep surgical site infection according to CDC criteria,burst abdomen at 1 months fascial wound defect combined with internal organ evisceration,Seroma at 1 and 3 months fluid collection in the area of incision or serous leakage through the wound,hematoma at 1 week a collection of a blood clot which needed evacuation,enterocutaneous fistula/ chronic wound sinus at 1, 3, 6, and 12 months abnormal opening at incision producing discharge with/without connecting to GI tract,acute postoperative pain day 1 and 3 pain score (from 0 to 10),chronic pain at 3, 6, 12, 18 and 24 months pain in any degree, persisting at the incisional scar,length of hospital stay at the beginning of the study a number of days spent on admission after the index operation,abdominal wall closure time at the beginning of the study time spend from the starting of abdominal wall closure to completing of skin approximation,mesh removal rate at 1, 3, 6, 12, 18, and 24 months removal from any reason ,cost at the beginning of study, 1, 3, 6, 12, 18, and 24 months All cost data, including direct medical, direct non-medical, and indirect costs, will be retrieved i

Countries

Thailand

Contacts

Public ContactAmarit Tansawet

Navamindradhiraj University

amarit@nmu.ac.th02-244-3282

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026